KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $161,000 | -4.2% | 30,389 | +21.9% | 0.00% | – |
Q1 2021 | $168,000 | -3.4% | 24,931 | -2.6% | 0.00% | – |
Q4 2020 | $174,000 | -2.2% | 25,606 | +7.6% | 0.00% | – |
Q3 2020 | $178,000 | -27.0% | 23,795 | 0.0% | 0.00% | – |
Q2 2020 | $244,000 | +92.1% | 23,795 | +64.3% | 0.00% | – |
Q1 2020 | $127,000 | +1170.0% | 14,479 | +1805.1% | 0.00% | – |
Q2 2018 | $10,000 | -94.6% | 760 | -93.5% | 0.00% | – |
Q1 2018 | $186,000 | +416.7% | 11,778 | +489.8% | 0.00% | – |
Q4 2017 | $36,000 | -75.2% | 1,997 | -68.6% | 0.00% | – |
Q3 2017 | $145,000 | – | 6,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |